Inflammatory myopathies with anti-ku antibodies: A prognosis dependent on associated lung disease

Medicine

Volumn 91, Issue 2, 2012, Pages 95-102

  Rigolet, Aude ^a   Musset, Lucile ^a   Dubourg, Odile ^a   Maisonobe, Thierry ^a   Grenier, Philippe ^a   Charuel, Jean Luc ^a   Behin, Anthony ^a   Herson, Serge ^a   Amoura, Zahir ^a   Benveniste, Olivier ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN; KU ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTICLE; AUTOIMMUNE THYROIDITIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRYOGLOBULINEMIA; DYSPHAGIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCLUSION BODY MYOSITIS; INTERSTITIAL LUNG DISEASE; LABORATORY; LUNG DISEASE; LUNG TUMOR; MALE; MUSCLE BIOPSY; MUSCLE NECROSIS; MUSCLE WEAKNESS; MYALGIA; MYOSITIS; PERICARDITIS; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; RAYNAUD PHENOMENON; REMISSION; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ANTIGENS, NUCLEAR; ARTHRALGIA; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOPSY; CREATINE KINASE; DEGLUTITION DISORDERS; DNA-BINDING PROTEINS; DRUG RESISTANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MYOSITIS; NECROSIS; PROGNOSIS; RAYNAUD DISEASE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84857806198     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e31824d9cec     Document Type: Article

References (27)

1. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324. (Pubitemid 18091653)
2. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344-347.
3. Cavazzana I, Ceribelli A, Quinzanini M, et al. Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. Lupus. 2008;17:727-732.
4. Cooley HM, Melny BJ, Gleeson R, et al. Clinical and serological associations of anti-Ku antibody. J Rheumatol. 1999;26:563-567. (Pubitemid 29125572)
5. Franceschini F, Cavazzana I, Generali D, et al. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J Rheumatol. 2002;29:1393-1397. (Pubitemid 34755602)
6. Francoeur AM, Peebles CL, Gompper PT, et al. Identification of Ki (Ku, p70/p80) autoantigens and analysis of anti-Ki autoantibody reactivity. J Immunol. 1986;136:1648-1653. (Pubitemid 16119570)
7. Ghirardello A, Zampieri S, Tarricone E, et al. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity. 2006;39:217-221. (Pubitemid 43879034)
8. Griggs RC, Askanas V, DiMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol. 1995;38:705-713.
9. Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller FW, et al. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum. 1997;40:1257-1266. (Pubitemid 27430137)
10. Koenig M, Fritzler MJ, Targoff IN, et al. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther. 2007;9:R78.
11. Koike M. Dimerization, translocation and localization of Ku70 and Ku80 proteins. J Radiat Res (Tokyo). 2002;43:223-236. (Pubitemid 135691177)
12. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28:1573-1576.
13. Mimori T, Akizuki M, Yamagata H, et al. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest. 1981;68:611-620. (Pubitemid 11005035)
14. Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol. 1999;17:615-620. (Pubitemid 29454836)
15. Nogalska A, Terracciano C, D'Agostino C, et al. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Acta Neuropathol. 2009;118:407-413.
16. Reeves WH. Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera. J Exp Med. 1985;161:18-39. (Pubitemid 15169718)
17. Rozman B, Cucnik S, Sodin-Semrl S, et al. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study. Ann Rheum Dis. 2008;67:1282-1286.
18. Schild-Poulter C, Su A, Shih A, et al. Association of autoantibodies with Ku and DNA repair proteins in connective tissue diseases. Rheumatology (Oxford). 2008;47:165-171. (Pubitemid 351168225)
19. Selva-O'Callaghan A, Labrador-Horrillo M, Solans-Laque R, et al. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum. 2006;55:791-798. (Pubitemid 44619194)
20. Silvera D, Koloteva-Levine N, Burma S, et al. Effect of Ku proteins on IRES-mediated translation. Biol Cell. 2006;98:353-361. (Pubitemid 43853422)
21. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277. (Pubitemid 13221242)
22. Troyanov Y, Targoff IN, Tremblay JL, et al. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore). 2005;84:231-249. (Pubitemid 41026298)
23. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-558. (Pubitemid 34539104)
24. Walker JR, Corpina RA, Goldberg J. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature. 2001;412:607-614. (Pubitemid 32772267)
25. Wang J, Satoh M, Kabir F, et al. Increased prevalence of autoantibodies to ku antigen in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum. 2001;44:2367-2370. (Pubitemid 32977505)
26. Yamamoto AM, Amoura Z, Johannet C, et al. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases. Arthritis Rheum. 2000;43:689-698. (Pubitemid 30394962)
27. Yaneva M, Arnett FC. Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol. 1989;76:366-372. (Pubitemid 19172264)